Format

Send to

Choose Destination
Pancreatology. 2019 Jan;19(1):182-190. doi: 10.1016/j.pan.2018.11.013. Epub 2018 Nov 27.

Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI).

Author information

1
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
2
Adelphi Values, Cheshire, England, United Kingdom. Electronic address: nicola.williamson@adelphivalues.com.
3
Abbott Product Operations AG, EPD HQ, Allschwil, Switzerland.
4
Adelphi Values, Cheshire, England, United Kingdom.
5
Charité University Hospital, Berlin, Germany.
6
University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
7
Université Denis Diderot-Paris VII Hôpital Beaujon, Clichy Cedex, France.
8
Southampton Children's Hospital, Hampshire, England, United Kingdom.
9
University Medicine Greifswald, Greifswald, Germany.

Abstract

BACKGROUND/OBJECTIVES:

Pancreatic exocrine insufficiency (PEI) is commonly caused by chronic pancreatitis (CP) or cystic fibrosis (CF). There are no PEI-specific patient-reported assessments of symptoms and impacts. The PEI Questionnaire (PEI-Q) was developed through qualitative research with PEI patients and expert clinical input. This study evaluated the psychometric properties of the PEI-Q.

METHODS:

162 PEI patients (CF = 71 and CP = 91), 62 diarrhoea-specific irritable bowel syndrome (IBS-D) patients and 60 healthy controls completed the 26-item PEI-Q and the Gastrointestinal Quality of Life Index (GIQLI) at baseline. PEI patients completed the measures again two weeks later to assess the test-retest reliability of the PEI-Q. Analyses supported item reduction and scoring algorithm development, followed by psychometric evaluation.

RESULTS:

Over 90% of PEI patients completed at least 23 of the 26 items at baseline. Item responses and clinical relevance supported retention of 18 items. Factor analysis supported a three-factor solution (abdominal symptoms, bowel movements, impacts) with adequate model fit. PEI-Q scores had good internal consistency (Cronbach's alpha: 0.77-0.82) and test-retest reliability (ICC: 0.73-0.87). Correlations between PEI-Q and GIQLI supported convergent validity. Known-groups and receiver operating characteristic analyses demonstrated that PEI-Q scores discriminated (p < 0.001) between differing PEI severities, and PEI patients and controls.

CONCLUSIONS:

The PEI-Q has good validity and reliability. Results indicate that the PEI-Q could be used to aid identification and diagnosis of PEI, assist in the management of patients already diagnosed with PEI, ensuring correct and optimum treatment as well as enhance patient-clinician communication.

KEYWORDS:

Health-related quality of life; Pancreatic exocrine insufficiency; Psychometric validation; Symptoms

PMID:
30528109
DOI:
10.1016/j.pan.2018.11.013
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center